Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) saw a significant growth in short interest in the month of August. As of August 14th, there was short interest totaling 113,543 shares, a growth of 343.9% from the July 30th total of 25,578 shares. Based on an average daily volume of 141,285 shares, the days-to-cover ratio is currently 0.8 days. Approximately 1.7% of the company’s shares are short sold.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the stock. Maxim Group lowered their target price on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating for the company in a research note on Tuesday, June 16th. Zacks Research downgraded Oxbridge Re from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 18th. Finally, Weiss Ratings upgraded shares of Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a report on Friday, August 14th. One analyst has rated the stock with a Buy rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $3.00.
View Our Latest Analysis on OXBR
Hedge Funds Weigh In On Oxbridge Re
Oxbridge Re Price Performance
Shares of OXBR stock traded down $0.01 during trading hours on Wednesday, hitting $1.28. The stock had a trading volume of 301 shares, compared to its average volume of 287,840. Oxbridge Re has a twelve month low of $0.66 and a twelve month high of $2.86. The firm has a market capitalization of $10.46 million, a PE ratio of 64.28 and a beta of 1.94. The stock’s 50 day moving average is $1.34 and its 200 day moving average is $1.08.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The insurance provider reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). The business had revenue of $0.94 million during the quarter, compared to analyst estimates of $1.10 million. Oxbridge Re had a net margin of 4.71% and a return on equity of 2.14%. As a group, equities analysts predict that Oxbridge Re will post -0.08 earnings per share for the current year.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Further Reading
- Five stocks we like better than Oxbridge Re
- OpenAI’s Jalapeño Chip Could Change the AI Hardware Race
- Gold and Bitcoin Are Rebounding—2 ETFs Give Investors a Different Kind of Exposure
- HONA: The Spin-Off Story the Market Is Reading Wrong
- Quantum Computing Is Raising the Stakes for Cybersecurity: 5 Stocks to Watch
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
